These results highlight the role digital therapeutics can play in helping companies understand the cost impact of their mental health programs. Digital therapeutics are uniquely equipped to do so because they can be delivered at scale, provide consistent care, and track clinical outcomes.

Dr. Michael Darden, health economist and associate professor at Johns Hopkins Carey Business School

Supporting employee mental health and sleep has a variety of benefits for both individual employees as well as the organization. And now, the health care cost impacts are quantified in this whitepaper that not only offers cutting-edge data but also replicates previous results.

Key insights: 

  • The prevalence of insomnia among employees in large organizations
  • Impact of poor sleep on individuals and businesses
  • How digital therapeutics (DTx) work and are scaled throughout populations
  • The relationship between DTx efficacy and health care cost savings
  • Implications for businesses like yours

A peek inside: 

Disclaimer: In accordance with FDA’s Current Enforcement Discretion Policy for Digital Health Devices for Psychiatric Disorders, for patients aged 18 years and older, who are followed by and diagnosed with insomnia disorder by a medical provider, Sleepio is available as an adjunct to their usual medical care for insomnia disorder. Sleepio does not replace the care of a medical provider or the patient’s medication. Sleepio has not been cleared by the U.S. Food and Drug Administration (FDA) for this indication.

Download the report

Cost of mental health, SleepShare article

About the Author

FDA black box warnings and anti-anxiety medications

Into the medicine cabinet: The benefits and downsides of benzodiazepines.

Blog/5 min read

Mental health medications: The double-edged sword

A journey into the medicine cabinet.

Blog/5 min read

The state of mental health equity

Insights from clinical experts focused on improving mental health disparities.


BigHealth Logo

Our mission is to help millions back to good mental health with evidence-based digital therapeutics for the most prevalent mental health conditions. We’re charting the future of digital medicine by providing an inclusive, scalable, and affordable approach based on industry-leading peer-reviewed research and randomized controlled trials. From member engagement to billing via pharmacy benefit managers, we simplify adoption for both payers and patients, improving access to mental health care.

Sign up for expert advice from the Big Health team

Leave a Reply

Your email address will not be published. Required fields are marked *